Anna Reni
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
-
- Gut microbiota and health
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- COVID-19 and healthcare impacts 1
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Michèle Milella (3 shared papers)Luca Landoni (1 shared paper)Jessica Menis (1 shared paper)Sara Cingarlini (2 shared papers)Taymeyah Al‐Toubah (1 shared paper)Mauro Cives (1 shared paper)Stefano Milleri (1 shared paper)Claudio Luchini (2 shared papers)
- Journals
- Annals of Oncology (1 paper)European Urology (1 paper)Journal of the National Comprehensive Cancer Network (1 paper)OncoImmunology (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Anna Reni
10 papers receiving 691 citations
Anna Reni's Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 343
- Molecular Biology 418
- Biotechnology 21
- Pulmonary and Respiratory Medicine 72
- Periodontics 6
Countries citing papers authored by Anna Reni
This map shows the geographic impact of Anna Reni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Reni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Reni more than expected).
Fields of papers citing papers by Anna Reni
This network shows the impact of papers produced by Anna Reni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Reni. The network helps show where Anna Reni may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Reni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 320 | |
| 2 | A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers Hit paper breakdown → | 2023 | 176 |
| 3 | Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome Hit paper breakdown → | 2024 | 136 |
| 4 | 2020 | 18 | |
| 5 | 2024 | 13 | |
| 6 | 2025 | 13 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 2 | |
| 10 | 2025 | 1 |
About Anna Reni
Anna Reni is a scholar working on Oncology, Epidemiology, Molecular Biology, Pulmonary and Respiratory Medicine and Nuclear Energy and Engineering, having authored 10 papers that have together received 695 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Neuroendocrine Tumor Research Advances (2 papers), Gut microbiota and health (2 papers), Epigenetics and DNA Methylation (1 paper), COVID-19 and healthcare impacts (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Oncology (343 citations), Molecular Biology (418 citations), Biotechnology (21 citations), Pulmonary and Respiratory Medicine (72 citations) and Periodontics (6 citations). Anna Reni has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Michèle Milella, Luca Landoni, Jessica Menis, Sara Cingarlini, Taymeyah Al‐Toubah, Mauro Cives, Stefano Milleri, Claudio Luchini, Camillo Porta and Silvia Palmerio. Their work appears in journals such as Annals of Oncology, European Urology, Journal of the National Comprehensive Cancer Network, OncoImmunology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.